Patents Assigned to FHG Corporation d/b/a integrity Nutraceuticals
  • Publication number: 20140072659
    Abstract: Materials derived from Nelumbo are administered orally to humans or animals for the purpose of enhancing creatine transport into skeletal tissue and for purposes of enhancing lean body mass. Enhancing creatine transport through improved insulin signaling is a new method of depositing creatine and enhancing lean body mass. Such administration is also used for enhancing athletic performance and controlling bodyweight and body fat levels. More specifically, such administration is used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material is administered as extracts of Nelumbo and administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.
    Type: Application
    Filed: November 12, 2013
    Publication date: March 13, 2014
    Applicant: FHG Corporation d/b/a Integrity Nutraceuticals
    Inventors: Tim Romero, Peter J. Miller, Bolin Qin
  • Publication number: 20130224317
    Abstract: A composition containing nelumbo extract reduces and/or eliminates one or more risk factors associated with Metabolic syndrome. The composition also includes optionally one of more components selected from the group consisting of vitamins, cholesterol lowering agents, lipid lowering agents, and glucose lowering agent. Also described is a method of reducing and/or eliminating risk factors associated with Metabolic syndrome in a subject through the administration of the nelumbo extract. The nelumbo extract supplement is administered orally, intravenously, or subcutaneously. In one embodiment, a daily dose of 10-1,000 mg of the extract supplement is administered to the subject for a period of 6 weeks to 6 months.
    Type: Application
    Filed: October 26, 2011
    Publication date: August 29, 2013
    Applicant: FHG CORPORATION D/B/A INTEGRITY NUTRACEUTICALS
    Inventor: Tim Romero
  • Publication number: 20130072574
    Abstract: A dietary supplement composition is provided for enhancing the expression of a sirtuin gene or protein. An inventive supplement composition includes at least one cinnamon extract containing at least 0.5% doubly linked Type-A polymers by dry weight. The cinnamon extract is derived from the Cinnamonum aromaticum, Cinnamonum verum or Cinnamonum burmannii plant. In some embodiments, the cinnamon extract is present at approximately 20%-50% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is optionally provided in the composition. The dietary supplement composition is administered orally to promote expression or enhanced expression of a sirtuin gene or protein.
    Type: Application
    Filed: May 26, 2011
    Publication date: March 21, 2013
    Applicant: FHG CORPORATION D/B/A INTEGRITY NUTRACEUTICALS
    Inventors: Peter J. Miller, Tim Romero, Bolin Qin, Augustin T. Romero
  • Publication number: 20130046018
    Abstract: A process for increasing lean body mass in a mammalian subject is provided that includes administering to the subject a purified quantity of maslinic acid, oleanolic acid, or a combination thereof. The administration can be orally and benefits from ingestion of an amino acid source such as dietary protein, oligopeptides, or amino acids. Administration within 2 hours of muscle-degrading exercise or on a daily basis for a period of time increases lean body mass.
    Type: Application
    Filed: October 18, 2012
    Publication date: February 21, 2013
    Applicant: FHG Corporation d/b/a Integrity Nutraceuticals
    Inventor: FHG Corporation d/b/a Integrity Nutraceuticals
  • Publication number: 20120128800
    Abstract: A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.
    Type: Application
    Filed: November 28, 2011
    Publication date: May 24, 2012
    Applicant: FHG Corporation d/b/a Integrity Nutraceuticals
    Inventors: Timothy J. Romero, Bolin Qin, Peter J. Miller
  • Publication number: 20110280973
    Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.
    Type: Application
    Filed: July 21, 2011
    Publication date: November 17, 2011
    Applicant: FHG Corporation d/b/a Integrity Nutraceuticals
    Inventors: Peter Miller, Timothy Romero
  • Publication number: 20090191290
    Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.
    Type: Application
    Filed: March 16, 2009
    Publication date: July 30, 2009
    Applicant: FHG Corporation d/b/a integrity Nutraceuticals
    Inventors: Peter Miller, Timothy Romero